MRC1 and ovarian carcinoma: A study carried out in Norway demonstrated that a lifetime risk of ovarian cancer of around 10% and a 20% risk of death from ovarian cancer give a lifetime risk of death from ovarian cancer of around 2% in women with an MMR gene mutation31.